Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: France Clear all

253 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20024
20034
20043
20055
20064
20076
20089
20097
201011
201110
201216
20139
201411
201517
201613
20177
20187
201916
202011
202114
202213
202313
202411
202520
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed173
Recruiting28
Unknown status20
Terminated17
Active, not recruiting7
Not yet recruiting4
Withdrawn2
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S24
Assistance Publique - Hôpitaux de Paris21
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète18
University Hospital, Grenoble17
University Hospital, Montpellier17
Eli Lilly and Company12
Medtronic MiniMed, Inc.10
Hospices Civils de Lyon9
Sanofi9
Centre Hospitalier Sud Francilien8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 1253
Diabetes Mellitus49
Diabetes Mellitus, Type 218
Hypoglycemia15
Insulin Resistance5
Autoimmune Diseases4
Diabetic Nephropathies3
Obesity3
Overweight3
Sleep Apnea Syndromes3

Trials

Showing 26 to 50 of 253. Each trial links to its page on Pharma Observatory.

153 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.